aniracetam is an approved drug
Compound class:
Synthetic organic
Comment: Based on this compound's allosteric action on AMPA receptor activity [1] it was used as the structural basis for the development of novel potential ampakines. These compounds are being investigated as nootropics and neuroprotective drugs for the treatment of Alzheimer's disease (AD) and other neurodegenerative conditions (see patent US6730677).
|
|
No information available. |
Mechanism Of Action and Pharmacodynamic Effects |
Aniracetam's anxiolytic action may be mediated through dopamine D2, nicotinic acetylcholine, and serotonin 5-HT2A receptors [2]. This compound also allosterically potentiates AMPA receptor activity [1]. |